Clinical Outcome and Prognostic Factors of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma in General Clinical Practice

MLA

Go, Tanigawa, et al. “Clinical Outcome and Prognostic Factors of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma in General Clinical Practice.” Japanese Journal of Clinical Oncology, vol. 41, Sept. 2011, pp. 1265–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ded5704f229dcd6917d66879d7b74fb6&authtype=sso&custid=ns315887.

APA

Go, T., Atsunari, K., Seiji, Y., Kazuo, N., Susumu, M., Jiro, K., Norio, M., Toshiaki, Y., Toshitsugu, O., Tsuneo, H., Hitoshi, T., Norio, N., & Yasutomo, N. (2011). Clinical Outcome and Prognostic Factors of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma in General Clinical Practice. Japanese Journal of Clinical Oncology, 41, 1265–1270.

Chicago

Go, Tanigawa, Kawashima Atsunari, Yamaguchi Seiji, Nishimura Kazuo, Miyoshi Susumu, Kajikawa Jiro, Meguro Norio, et al. 2011. “Clinical Outcome and Prognostic Factors of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma in General Clinical Practice.” Japanese Journal of Clinical Oncology 41 (September): 1265–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ded5704f229dcd6917d66879d7b74fb6&authtype=sso&custid=ns315887.